MCFT(MCFT)
MCFT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $340M | $635M |
| Low | $333M | $628M |
| High | $348M | $642M |
| EBITDA Avg | $51M | $96M |
| Low | $50M | $95M |
| High | $52M | $97M |
| EBIT Avg | $44M | $81M |
| Low | $43M | $81M |
| High | $45M | $82M |
| Net Income Avg | $32M | $35M |
| Low | $30M | $34M |
| High | $34M | $36M |
| EPS Avg | $1.92 | $2.13 |
| Low | $1.80 | $2.07 |
| High | $2.04 | $2.20 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $76M | $77M | $86M | $101M | $138M | $155M | $163M | $179M |
| Low | $74M | $76M | $84M | $98M | $135M | $152M | $159M | $175M |
| High | $78M | $79M | $88M | $103M | $141M | $159M | $166M | $183M |
| EBITDA Avg | $11M | $12M | $13M | $15M | $21M | $23M | $24M | $27M |
| Low | $11M | $11M | $13M | $15M | $20M | $23M | $24M | $26M |
| High | $12M | $12M | $13M | $15M | $21M | $24M | $25M | $28M |
| EBIT Avg | $10M | $10M | $11M | $13M | $18M | $20M | $21M | $23M |
| Low | $10M | $10M | $11M | $13M | $17M | $19M | $20M | $22M |
| High | $10M | $10M | $11M | $13M | $18M | $20M | $21M | $23M |
| Net Income Avg | $6M | $6M | $8M | $12M | $6M | $7M | $9M | $13M |
| Low | $6M | $5M | $8M | $12M | $6M | $7M | $9M | $13M |
| High | $6M | $6M | $9M | $13M | $6M | $7M | $9M | $14M |
| EPS Avg | $0.36 | $0.34 | $0.51 | $0.74 | $0.37 | $0.41 | $0.54 | $0.81 |
| Low | $0.35 | $0.33 | $0.49 | $0.72 | $0.36 | $0.40 | $0.53 | $0.79 |
| High | $0.37 | $0.35 | $0.52 | $0.77 | $0.38 | $0.42 | $0.56 | $0.84 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |